Frank Anders Wilson's most recent trade in Alkermes plc was a trade of 8,013 Restricted Stock Unit Award done . Disclosure was reported to the exchange on May 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 33,008 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Frank Anders Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.61 per share. | 31 May 2025 | 1,924 | 31,084 (0%) | 0% | 30.6 | 58,894 | Ordinary Shares |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,474 | 13,474 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 6,142 | 6,142 | - | - | Restricted Stock Unit Award | |
| Cabot Corp. | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 1,788 | 16,254 (0%) | 0% | 0 | Common Stock | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,325 | 1,325 | - | - | Restricted Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 1,217 | 2,622 (0%) | 0% | - | Common Stock | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 1,217 | 0 | - | - | Restricted Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 278 | 1,405 (0%) | 0% | - | Common Stock | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 278 | 0 | - | - | Restricted Stock Units | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 26,460 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Frank Anders Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 29 Jun 2024 | 1,465 | 24,995 (0%) | 0% | 24.1 | 35,307 | Ordinary Shares |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,492 | 17,492 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 8,013 | 8,013 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 1,236 | 63,036 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 313 | 15,990 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 256 | 13,079 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 254 | 12,986 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 231 | 11,785 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 230 | 11,739 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 224 | 11,424 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Other type of transaction at price $ 0.00 per share. | 31 May 2024 | 119 | 6,104 | - | - | Restricted Stock Unit Award | |
| Cabot Corp. | Wilson Frank Anders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 2,035 | 14,466 (0%) | 0% | 0 | Common Stock | |
| Novanta Inc | Wilson Frank Anders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,217 | 1,217 | - | - | Restricted Stock Units | |
| Novanta Inc | Anders Frank Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 464 | 0 | - | - | Restricted Stock Units | |
| Novanta Inc | Wilson Anders Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 464 | 1,127 (0%) | 0% | - | Common Stock | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 21,786 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.88 per share. | 07 Jul 2023 | 1,430 | 20,356 (0%) | 0% | 29.9 | 42,728 | Ordinary Shares |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 278 | 278 | - | - | Restricted Stock Units | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 12,732 | 12,732 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 5,985 | 5,985 | - | - | Restricted Stock Unit Award | |
| Cabot Corp. | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 1,854 | 12,431 (0%) | 0% | 0 | Common Stock | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 520 | 1,223 | - | - | Deferred Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 464 | 464 | - | - | Restricted Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 359 | 0 | - | - | Restricted Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 359 | 663 (0%) | 0% | - | Common Stock | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 11,554 | 11,554 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,957 | 5,957 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 7,585 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 7,585 | 16,524 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Frank Anders Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.19 per share. | 14 Jun 2022 | 695 | 15,829 (0%) | 0% | 27.2 | 18,897 | Ordinary Shares |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 304 | 0 | - | - | Restricted Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 304 | 304 (0%) | 0% | - | Common Stock | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 40 | 703 | - | - | Deferred Stock Units | |
| Cabot Corp. | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 2,254 | 10,577 (0%) | 0% | 0 | Common Stock | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 359 | 663 | - | - | Deferred Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 359 | 359 | - | - | Restricted Stock Units | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 6,104 | 6,104 (0%) | 0% | 0 | Ordinary Shares | |
| Alkermes plc | Frank Anders Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 6,104 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Frank Anders Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.92 per share. | 20 May 2021 | 1,404 | 4,700 (0%) | 0% | 21.9 | 30,776 | Ordinary Shares |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 304 | 304 | - | - | Restricted Stock Units | |
| Novanta Inc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 304 | 304 | - | - | Deferred Stock Units | |
| Cabot Corp. | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 2,489 | 8,323 (0%) | 0% | 0 | Common Stock | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 11,509 | 11,509 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Frank Anders Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 5,578 | 5,578 | - | - | Restricted Stock Unit Award |